Abstract
Daptomycin is a novel lipopeptide antibiotic agent approved for the treatment of gram-positive life-threatening infections. Here we report, for the first time, the isolation of a highly daptomycin-resistant strain of Corynebacterium jeikeium causing a life-threatening infection in a neutropenic patient undergoing cord blood transplantation for secondary acute myeloid leukemia.
MeSH terms
-
Anti-Bacterial Agents / pharmacology*
-
Cord Blood Stem Cell Transplantation / adverse effects
-
Corynebacterium / drug effects*
-
Corynebacterium / isolation & purification*
-
Corynebacterium Infections / microbiology*
-
Daptomycin / pharmacology*
-
Humans
-
Leukemia, Myeloid, Acute / complications
-
Male
-
Microbial Sensitivity Tests
-
Middle Aged
Substances
-
Anti-Bacterial Agents
-
Daptomycin